ArticleOdontology2026
Cytokeratin 13 and 17 expressions in oral epithelial dysplasia: correlation with the 5th WHO architectural and cytological features.
Article in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Recently, the WHO 5th edition has modified the new architectural and cytological features for the diagnosis of oral epithelial dysplasia (OED). However, the correlation of these histopathological features with malignant transformation (MT) and recurrence (RE) of the lesions remains controversial. There is no study investigated the association between architectural and cytological features of the 5th WHO criteria with a reliable diagnostic marker for MT in OED. Therefore, this study aimed to correlate the 5th edition WHO histopathological diagnostic criteria of OED with the immunohistochemical expression of CK13/CK17, one of reliable diagnostic markers for MT in OED. A total of 32 samples of leukoplakia, erythroplakia, and erythroleukoplakia which histologically proved OED were included in the study. The specimens were graded according to 5th edition WHO criteria and categorized as 15 mild OED and 17 moderate to severe OED. The architectural and cytological features from the 5th WHO diagnostic criteria for OED were collected. The CK13/CK17 immunohistochemistry was performed. The CK13 and CK17 expression was graded semi-quantitatively. The association between architectural and cytological features with CK13/CK17 immunohistochemical expression and with histopathological diagnosis were analyzed. Eight histopathological features: irregular epithelial stratification, reduced keratinocyte cohesion, abnormal variation in nuclear size and shape, abnormal variation in cell size and shape, single cell keratinization and increased nuclear size were significantly correlated with CK13 weak/CK17 strong expression pattern and the diagnosis of moderate to severe OED (p < 0.05). Larger samples are required to enhance the accuracy in the diagnosis and prediction in the OED lesions.
Indexed as
Identifiers
42518059What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.